Ads
related to: stelara for crohn's disease- STELARA® Videos
View Short Educational Videos
to Help Inform Patient Care.
- STELARA® Dosing
Dosing & Administration
Important Safety Info
- STELARA® Support
Find Cost & Support Resources to
Help Patients With Their Treatment
- Patient Resources
Visit HCP Site to
Find Resources for Your Patients.
- Info for Physicians
Physicians - Find Safety, Dosing
& Clinical Data for STELARA®.
- Practice Resources
Visit HCP Site to
Find Resources for Your Practice.
- STELARA® Videos
Search results
From Nurse To Patient: My Journey With Crohn’s Disease
Women's Health via Yahoo News· 2 years agoAs a healthcare professional, Alison spent her days doing endoscopies, which are one of the many...
J&J’s Tremfya superior to Stelara in Phase II/III Chron’s disease trials
Clinical Trials Arena via Yahoo Finance· 1 week agoJohnson and Johnson’s Johnson and Johnson’s Tremfya (guselkumab) was superior to its Stelara...
AbbVie's (ABBV) Skyrizi Crohn's Disease Study Meets Goals
Zacks via Yahoo Finance· 9 months agoAbbVie's (ABBV) Skyrizi met both primary endpoints of non-inferiority for clinical remission at week...
FDA Approves First Oral Treatment For Crohn's Disease, Making Seventh Approval For AbbVie's Rinvoq
Benzinga via Yahoo Finance· 1 year agoThe FDA approved AbbVie Inc's (NASDAQ: ABBV) Rinvoq (upadacitinib) for moderately to severely active...
Bristol Myers' (BMY) Zeposia Fails Crohn's Disease Study
Zacks via Yahoo Finance· 2 months agoBristol Myers BMY announced that a late-stage study on orally-administered Zeposia (ozanimod) in...
Lilly (LLY) Hits Record High on Crohn's Disease Study Data
Zacks via Yahoo Finance· 1 week agoShares of Eli Lilly LLY rose nearly 3% on Tuesday after it reported detailed one-year results from...
Analysis-Stelara patent deal puts J&J back on path to $57 billion 2025 revenue forecast
Reuters via Yahoo Finance· 12 months agoJohnson & Johnson's legal settlement with Amgen Inc to delay a biosimilar version of its blockbuster...
What Could This Drug News Mean for AbbVie?
Motley Fool· 2 years agoIn late July, AbbVie (NYSE: ABBV) applied for a new indication with the European Medicines Agency (EMA) for Rinvoq to treat adult patients with...
Johnson & Johnson Clocks 12% Q4 Revenue Growth, Led By Cancer and Crohn's Disease Drugs
Benzinga via Yahoo Finance· 4 months agoOn Tuesday, Johnson & Johnson (NYSE:JNJ) reported fourth-quarter 2023 adjusted earnings of $2.29 per...
Lilly's bowel disease drug succeeds in late-stage study
Reuters via Yahoo News· 8 months agoThe drug was also shown not to be inferior to Johnson & Johnson's Stelara in helping symptoms of the...
Ads
related to: stelara for crohn's disease